Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.5 | 0.001 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |